NYSE:BHC Bausch Health Cos (BHC) Stock Price, News & Analysis $6.19 +0.46 (+8.08%) Closing price 06/18/2025 03:59 PM EasternExtended Trading$6.26 +0.06 (+1.00%) As of 06/18/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Bausch Health Cos Stock (NYSE:BHC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Bausch Health Cos alerts:Sign Up Key Stats Today's Range$5.78▼$6.3150-Day Range$4.33▼$6.1952-Week Range$3.96▼$9.85Volume4.64 million shsAverage Volume2.63 million shsMarket Capitalization$2.29 billionP/E RatioN/ADividend YieldN/APrice Target$7.42Consensus RatingReduce Company OverviewBausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.Read More… Bausch Health Cos Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks75th Percentile Overall ScoreBHC MarketRank™: Bausch Health Cos scored higher than 75% of companies evaluated by MarketBeat, and ranked 152nd out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.9 / 5Analyst RatingReduce Consensus RatingBausch Health Cos has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on no buy ratings, 6 hold ratings, and 1 sell rating.Amount of Analyst CoverageBausch Health Cos has only been the subject of 1 research reports in the past 90 days.Read more about Bausch Health Cos' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth5.67% Earnings GrowthEarnings for Bausch Health Cos are expected to grow by 5.67% in the coming year, from $4.41 to $4.66 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Bausch Health Cos is -56.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Bausch Health Cos is -56.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Bausch Health Cos' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted2.96% of the float of Bausch Health Cos has been sold short.Short Interest Ratio / Days to CoverBausch Health Cos has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in Bausch Health Cos has recently increased by 5.39%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBausch Health Cos does not currently pay a dividend.Dividend GrowthBausch Health Cos does not have a long track record of dividend growth. Sustainability and ESG4.0 / 5Environmental Score-1.42 Percentage of Shares Shorted2.96% of the float of Bausch Health Cos has been sold short.Short Interest Ratio / Days to CoverBausch Health Cos has a short interest ratio ("days to cover") of 4.2.Change versus previous monthShort interest in Bausch Health Cos has recently increased by 5.39%, indicating that investor sentiment is decreasing significantly. News and Social Media4.1 / 5News Sentiment1.47 News SentimentBausch Health Cos has a news sentiment score of 1.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 21 news articles for Bausch Health Cos this week, compared to 5 articles on an average week.Search Interest16 people have searched for BHC on MarketBeat in the last 30 days. This is an increase of 78% compared to the previous 30 days.MarketBeat Follows4 people have added Bausch Health Cos to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Bausch Health Cos insiders have bought more of their company's stock than they have sold. Specifically, they have bought $35,870,767.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 8.05% of the stock of Bausch Health Cos is held by insiders.Percentage Held by Institutions78.65% of the stock of Bausch Health Cos is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Bausch Health Cos' insider trading history. Receive BHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bausch Health Cos and its competitors with MarketBeat's FREE daily newsletter. Email Address BHC Stock News HeadlinesBausch Health Cos Inc. (NYSE:BHC) Director John Paulson Acquires 3,564,059 SharesJune 18 at 5:20 AM | insidertrades.comBausch Health Companies Inc. (NYSE:BHC) Director John Paulson Buys 754,134 SharesJune 13, 2025 | insidertrades.comMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.June 19, 2025 | American Alternative (Ad)John Paulson Acquires 3,564,059 Shares of Bausch Health Cos Inc. (NYSE:BHC) StockJune 19 at 4:09 AM | americanbankingnews.comBausch Health Cos (NYSE:BHC) Trading Up 7.9% Following Insider Buying ActivityJune 19 at 1:13 AM | americanbankingnews.comBausch Health Cos Inc. (NYSE:BHC) Receives $7.42 Consensus Price Target from BrokeragesJune 18 at 1:27 AM | americanbankingnews.comRepricing Potential Driven By DeleveragingJune 16 at 5:03 AM | seekingalpha.comBausch Health Companies (NYSE:BHC) Shares Gap Up After Insider Buying ActivityJune 15, 2025 | americanbankingnews.comSee More Headlines BHC Stock Analysis - Frequently Asked Questions How have BHC shares performed this year? Bausch Health Cos' stock was trading at $8.06 at the start of the year. Since then, BHC shares have decreased by 23.2% and is now trading at $6.1930. View the best growth stocks for 2025 here. How were Bausch Health Cos' earnings last quarter? Bausch Health Cos Inc. (NYSE:BHC) announced its earnings results on Wednesday, February, 19th. The company reported $1.21 EPS for the quarter, missing analysts' consensus estimates of $1.65 by $0.44. The company earned $2.56 billion during the quarter, compared to analyst estimates of $2.51 billion. Bausch Health Cos had a negative net margin of 0.41% and a negative trailing twelve-month return on equity of 540.45%. Read the conference call transcript. Who are Bausch Health Cos' major shareholders? Bausch Health Cos' top institutional shareholders include Nomura Holdings Inc. (6.46%), Vanguard Group Inc. (3.24%), Royal Bank of Canada (2.32%) and ING Groep NV (1.38%). Insiders that own company stock include John Paulson and Seana Carson. View institutional ownership trends. How do I buy shares of Bausch Health Cos? Shares of BHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Bausch Health Cos own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Cos investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Tesla (TSLA), Bristol Myers Squibb (BMY) and Gilead Sciences (GILD). Company Calendar Last Earnings2/19/2025Today6/18/2025Next Earnings (Estimated)7/30/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED - GENERIC DRG Sub-IndustryPharmaceutical Products Current SymbolNYSE:BHC CIK885590 Webwww.bauschhealth.com Phone(514) 744-6792Fax514-744-6272Employees20,700Year FoundedN/APrice Target and Rating Average Stock Price Target$7.42 High Stock Price Target$10.00 Low Stock Price Target$3.00 Potential Upside/Downside+19.8%Consensus RatingReduce Rating Score (0-4)1.86 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)($0.11) Trailing P/E RatioN/A Forward P/E Ratio1.40 P/E GrowthN/ANet Income-$46 million Net Margins-0.41% Pretax Margin1.94% Return on Equity-540.45% Return on Assets5.26% Debt Debt-to-Equity RatioN/A Current Ratio1.35 Quick Ratio0.97 Sales & Book Value Annual Sales$9.63 billion Price / Sales0.24 Cash Flow$8.04 per share Price / Cash Flow0.77 Book Value($0.89) per share Price / Book-6.96Miscellaneous Outstanding Shares370,080,000Free Float340,032,000Market Cap$2.29 billion OptionableOptionable Beta0.28 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NYSE:BHC) was last updated on 6/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Cos Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Cos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.